Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

207.19 -12.56 (-5.72%)
Streaming Delayed Price Updated: 3:15 PM EDT, Jul 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Which S&P500 stocks are moving after the closing bell on Wednesday? ↗
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with... 
Via StockStory
Topics Artificial Intelligence
News headline image
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For April 23, 2025 ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 6 Analysts Discuss ResMed Stock ↗
 
Via Benzinga
News headline image
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday? ↗
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
News headline image
A Look Ahead: ResMed's Earnings Forecast ↗
 
Via Benzinga
News headline image
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
Resmed Names Salli Schwartz as Chief Investor Relations Officer
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community 
From Resmed, Inc.
Via GlobeNewswire
News headline image
Assessing ResMed: Insights From 5 Financial Analysts ↗
 
Via Benzinga
News headline image
Why RESMED INC (NYSE:RMD) is a Top Pick for Dividend Investors. ↗
Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD). 
Via Chartmill
News headline image
Which S&P500 stocks are gapping on Tuesday? ↗
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
News headline image
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. 
Via StockStory
Topics Artificial Intelligence
News headline image
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosis 
From Resmed, Inc.
Via GlobeNewswire
News headline image
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
Why RESMED INC (NYSE:RMD) Deserves Consideration as a Quality Investment. ↗
A fundamental analysis of (NYSE:RMD): Is RESMED INC (NYSE:RMD) suited for quality investing? 
Via Chartmill
News headline image
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. 
Via StockStory
Topics Artificial Intelligence
News headline image
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of... 
From Resmed, Inc.
Via GlobeNewswire
News headline image
Tempted To Dump Stock? Consider Shifting To Low Vol Stocks / ETFs Instead ↗
While plummeting stock indexes sent some investors screaming for the exits, others look to shift assets from large-cap tech stocks and cap-weighted ETFs into less volatile investments.. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone 
From Resmed, Inc.
Via GlobeNewswire
News headline image
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest... 
Via StockStory
Topics Artificial Intelligence
News headline image
Top S&P500 movers in Monday's session ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Wednesday. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Gapping S&P500 stocks in Wednesday's session ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
2 Reasons to Like RMD and 1 to Stay Skeptical
Since September 2024, ResMed has been in a holding pattern, posting a small loss of 4.8% while floating around $233.10. The stock also fell short of the S&P 500’s 6.2% gain during that period. 
Via StockStory
Topics Stocks
News headline image
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom... 
Via StockStory
Topics Artificial Intelligence
News headline image
Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.